{"id":70711,"date":"2026-05-12T09:38:54","date_gmt":"2026-05-12T09:38:54","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70711"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"dsip","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/dsip\/","title":{"rendered":"DSIP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le DSIP ?<\/h3>\n<p style=\"margin: 0;\"><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide first isolated from rabbit cerebral venous blood during electrical stimulation of thalamic sleep-promoting regions in 1977. In published studies it modulates sleep architecture \u2014 specifically slow-wave (delta) sleep \u2014 alongside documented effects on stress reactivity, withdrawal syndromes, and nociception. Supplied in 5\u00a0mg to 15\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">62568-57-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">848.81 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE, 9 acides amin\u00e9s ; lin\u00e9aire, extr\u00e9mit\u00e9s non modifi\u00e9es)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (blanche \u00e0 blanc cass\u00e9)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le DSIP ?<\/h2>\n<p><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid linear neuropeptide first isolated by Schoenenberger and Monnier at the University of Basel in 1977. The peptide was identified by dialysing cerebral venous blood from rabbits during electrical stimulation of the intralaminar thalamus \u2014 a region known to drive delta-wave (slow-wave) sleep in the cortex \u2014 and concentrating the bioactive fraction. DSIP was named for the dominant electroencephalographic signature it produced when administered to recipient animals: increased proportion of delta-wave activity during sleep. The well-characterised sequence is WAGGDASGE, molecular weight 848.81\u00a0Da, empirical formula C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub>. Le DSIP est structurellement inhabituel parmi les petits peptides actifs dans le SNC \u2014 il est lin\u00e9aire, non modifi\u00e9 aux deux extr\u00e9mit\u00e9s et ne contient aucun r\u00e9sidu de proline ou de cyst\u00e9ine. Le peptide est fourni sous forme de poudre lyophilis\u00e9e de haute puret\u00e9 pour reconstitution avec de l'eau bact\u00e9riostatique. Le DSIP est <strong>non approuv\u00e9<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For related circadian and sleep-axis peptide studies, see our <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> et <a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a> pages produit. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Architecture du sommeil, r\u00e9activit\u00e9 au stress et neuroprotection<\/h2>\n<p>What makes DSIP unusual among peptides is the breadth of effects documented for such a small, linear peptide without a clearly identified primary receptor. Published studies has mapped its activity across <strong>trois domaines qui se chevauchent<\/strong>, chacun contribuant au ph\u00e9notype observ\u00e9 :<\/p>\n<ul>\n<li><strong>Modulation de l'architecture du sommeil \u2014 sommeil \u00e0 ondes delta (sommeil lent)<\/strong> \u2014 DSIP increases the proportion of slow-wave (stage 3\u20134 \/ N3) sleep on quantitative EEG measurements in rodent, rabbit, and human studies without proportionally reducing REM sleep. The effect is most pronounced when DSIP is administered to subjects with fragmented or shortened sleep, suggesting the peptide acts as a homeostatic sleep-pressure modulator rather than a primary sedative. Importantly, DSIP does not directly increase total sleep time in non-sleep-deprived subjects \u2014 it reorganises sleep architecture toward higher SWS proportion.<\/li>\n<li><strong>Modulation de l'axe HPA et de la r\u00e9activit\u00e9 au stress<\/strong> \u2014 Plusieurs \u00e9tudes publi\u00e9es documentent une att\u00e9nuation de la lib\u00e9ration de cortisol et d'ACTH induite par le stress dans des mod\u00e8les de stress par contention chez les rongeurs, ainsi qu'une r\u00e9duction de la signalisation de l'hormone de lib\u00e9ration de la corticotropine (CRH) dans l'hypothalamus. L'effet tampon contre le stress op\u00e8re sur une \u00e9chelle de temps plus longue que les s\u00e9datifs benzodiaz\u00e9piniques et ne produit pas de s\u00e9dation comportementale aigu\u00eb, sugg\u00e9rant une modulation du tonus de l'axe HPA plut\u00f4t qu'une anxiolyse aigu\u00eb.<\/li>\n<li><strong>Anti-nociception, neuroprotection et anti-sevrage<\/strong> \u2014 DSIP shows analgesic effects in rodent thermal and chemical-nociception models, including opioid-naive subjects (suggesting non-opioid mechanism). Russian and Eastern European has documented attenuation of opioid and alcohol withdrawal syndromes in preclinical models. Neuroprotective effects against oxidative stress, ischaemia, and excitotoxicity have been reported but remain mechanistically less well characterised than the sleep architecture work.<\/li>\n<\/ul>\n<p>The receptor target for DSIP has not been definitively identified, which is unusual for a peptide with this much published behavioural data. Proposed mechanisms include GABA-A modulation, opioid-system crosstalk, and direct interaction with hypothalamic CRH neurons. The lack of an identified primary receptor combined with multiple documented effects suggests DSIP may act as a multimodal neuromodulator rather than a classical receptor agonist \u2014 a hypothesis that remains an active studies question in published peptide pharmacology. <\/p>\n<h2>Published Evidence<\/h2>\n<p>DSIP is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Sleep architecture and EEG studies<\/strong> \u2014 quantitative EEG spectral analysis, slow-wave sleep proportion, sleep fragmentation in rodent and human studies (Schoenenberger &amp; Monnier, PNAS 1977; Kovalzon &amp; Strekalova, Sleep Med Rev 2006)<\/li>\n<li><strong>Stress reactivity and HPA-axis studies<\/strong> \u2014 dynamique du cortisol et de l'ACTH, expression de la CRH, mod\u00e8les de stress par contention et de stress chronique l\u00e9ger chez les rongeurs<\/li>\n<li><strong>Withdrawal syndrome studies<\/strong> \u2014 gravit\u00e9 du sevrage aux opio\u00efdes, sevrage alcoolique, r\u00e9duction progressive des benzodiaz\u00e9pines ; litt\u00e9rature principalement publi\u00e9e en Russie et en Europe de l'Est<\/li>\n<li><strong>Nociception and chronic pain studies<\/strong> \u2014 mod\u00e8les de claquement de queue, plaque chauffante, formaline et l\u00e9sion par constriction chronique chez les rongeurs ; caract\u00e9risation des m\u00e9canismes non opio\u00efdes<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 marqueurs de stress oxydatif, l\u00e9sion d'isch\u00e9mie-reperfusion, mod\u00e8les d'excitotoxicit\u00e9<\/li>\n<li><strong>Circadian biology studies<\/strong> \u2014 entra\u00eenement, r\u00e9ponse de d\u00e9calage de phase, modulation des rythmes de m\u00e9latonine et de temp\u00e9rature corporelle centrale<\/li>\n<li><strong>Comparative sleep-axis peptide studies<\/strong> \u2014 \u00e9valuation comparative contre <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (t\u00e9trapeptide pin\u00e9al) pour les effets circadiens et contre <a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a> pour les effets tampons du stress sans s\u00e9dation.<\/li>\n<\/ul>\n<p>Pour un contexte plus large sur la place du DSIP dans le paysage des petits peptides actifs sur le SNC, voir <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (AEDG pineal tetrapeptide, circadian-axis studies), <a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a> (heptapeptide anxiolytique), et <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> (heptapeptide nootropique). Parcourez l'int\u00e9gralit\u00e9 du <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a> pour les compos\u00e9s associ\u00e9s. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase stocks DSIP in three lyophilized vial sizes covering pilot dosing through extended protocols. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, single-EEG-session studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, multi-week sleep-architecture studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>15\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoles \u00e0 cycles prolong\u00e9s, co\u00fbt par mg le plus bas, \u00e9tudes multi-cohortes<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols or run extended studies from a single vial. <\/p>\n<h2>Comparaison \u2014 DSIP vs Epitalon<\/h2>\n<p>DSIP et <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> are the two most-cited small peptides involved in sleep, circadian, and rest-state studies. They share several studies-relevant features \u2014 both are short, linear, unmodified peptides without identified primary receptors, and both produce phenotypic effects that outlast plasma clearance \u2014 but their primary signals are distinct: DSIP modulates sleep architecture directly via SWS proportion; Epitalon acts on the pineal-melatonin axis and circadian gene expression. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">DSIP<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longueur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 acides amin\u00e9s (lin\u00e9aire)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 acides amin\u00e9s (t\u00e9trapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">WAGGDASGE<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">AEDG (Ala-Glu-Asp-Gly)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Proportion de sommeil \u00e0 ondes lentes (delta EEG)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Axe pin\u00e9al-m\u00e9latonine, t\u00e9lom\u00e9rase, expression des g\u00e8nes circadiens<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>R\u00e9cepteur identifi\u00e9<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aucun (neuromodulateur multimodal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aucun (r\u00e9gulation g\u00e9nique, intracellulaire)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose typique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500 mcg, 1 fois par jour<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg, 1 fois par jour pour les cycles<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>D\u00e9but de l'effet<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">M\u00eame session (mesurable par EEG)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Plusieurs semaines (\u00e9chelle temporelle d'expression g\u00e9nique)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilement<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Co-administered with Epitalon in circadian-sleep stack studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Co-administr\u00e9 avec le DSIP pour des effets combin\u00e9s sommeil+circadiens<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For sleep-architecture studies, DSIP is the canonical first choice because it produces measurable EEG-level effects on slow-wave sleep proportion within a single sleep session. For circadian-rhythm and gene-regulatory studies, Epitalon is preferred because the effect timescale matches the underlying biology (gene expression changes over days to weeks). The two are frequently co-administered when both axes are part of the studies question. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> Conservez les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C dans leur emballage d'origine pour le stock de travail \u00e0 court terme. Pour le stockage \u00e0 long terme non ouvert, congelez \u00e0 \u221220 \u00b0C. Le DSIP lyophilis\u00e9 est stable sous r\u00e9frig\u00e9ration jusqu'\u00e0 24 mois et \u00e0 \u221220 \u00b0C jusqu'\u00e0 36 mois. \u00c9vitez les cycles de gel-d\u00e9gel sur la poudre lyophilis\u00e9e. Le DSIP est hygroscopique \u2014 refermez rapidement les flacons apr\u00e8s ouverture et conservez-les dans un contenant dess\u00e9ch\u00e9 si disponible. <strong>Proc\u00e9dure de reconstitution :<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose. Swirl gently \u2014 do <strong>re\u00e7oit pas<\/strong> secouer \u2014 et laisser 2 \u00e0 5 minutes pour une dissolution compl\u00e8te. Une solution correctement reconstitu\u00e9e doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> conservez au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C et utilisez dans les 30 jours pour une stabilit\u00e9 optimale. Ne congelez pas la solution reconstitu\u00e9e \u2014 les cycles de gel-d\u00e9gel d\u00e9gradent l'int\u00e9grit\u00e9 du peptide. Jetez tout flacon pr\u00e9sentant de la turbidit\u00e9, un pr\u00e9cipit\u00e9 ou une d\u00e9coloration. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is DSIP used for in studies?<\/h3>\n<p>DSIP is used in studies investigating sleep architecture (particularly slow-wave sleep proportion), HPA-axis and stress reactivity, opioid and alcohol withdrawal syndromes, non-opioid analgesia, neuroprotection, and circadian biology. It is the most-cited sleep-axis peptide that does not act primarily as a sedative \u2014 effects manifest as reorganisation of sleep architecture rather than increased total sleep time. The pharmaceutical-grade DSIP sold here is <strong>re\u00e7oit pas<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>En quoi le DSIP diff\u00e8re-t-il de l'\u00c9pitalon ?<\/h3>\n<p>Both are small unmodified peptides without identified primary receptors that influence rest-state biology, but their primary signals differ. DSIP modulates sleep architecture at the EEG level \u2014 specifically increasing slow-wave sleep proportion within a single sleep session. Epitalon acts on the pineal-melatonin axis and circadian gene expression on a gene-expression timescale of days to weeks. The two are mechanistically complementary and frequently co-administered in studies investigating combined sleep and circadian endpoints. <\/p>\n<h3>What is the typical DSIP dose?<\/h3>\n<p>Les protocoles pr\u00e9cliniques publi\u00e9s utilisent g\u00e9n\u00e9ralement 100 \u00e0 500 mcg par administration dans des mod\u00e8les rongeurs, administr\u00e9s par voie sous-cutan\u00e9e ou intrap\u00e9riton\u00e9ale une fois par jour pendant des cycles de 7 \u00e0 28 jours. Un flacon de 5 mg reconstitu\u00e9 avec 2,0 mL d'eau bact\u00e9riostatique donne une concentration de 2,5 mg\/mL \u2014 0,04 mL \u00e9quivaut \u00e0 100 mcg. <\/p>\n<h3>Le DSIP est-il approuv\u00e9 par la FDA ?<\/h3>\n<p>No. DSIP is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h3>Comment le DSIP doit-il \u00eatre stock\u00e9 ?<\/h3>\n<p>Flacons lyophilis\u00e9s : r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C pour le stock de travail \u00e0 court terme, ou \u00e0 \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Le DSIP est hygroscopique \u2014 refermez les flacons rapidement apr\u00e8s ouverture. Solution reconstitu\u00e9e : r\u00e9frig\u00e9r\u00e9e \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne congelez pas la solution reconstitu\u00e9e \u2014 les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation d\u00e9gradent le peptide. Prot\u00e9gez-le toujours de la lumi\u00e8re directe. <\/p>\n<h3>Comment reconstituer le DSIP ?<\/h3>\n<p>Suivez la proc\u00e9dure de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi du flacon (pas directement sur la poudre lyophilis\u00e9e), agitez doucement et laissez reposer 2 \u00e0 5 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> Secouez le flacon. Une solution correctement reconstitu\u00e9e est claire et incolore. Pour un flacon de 5 mg + 2,0 mL de diluant, la concentration de travail est de 2,5 mg\/mL. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase carries DSIP in 5\u00a0mg, 10\u00a0mg, and 15\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Does DSIP cause sedation in study models?<\/h3>\n<p>No \u2014 this is one of the most-cited findings in DSIP studies. Unlike benzodiazepines or other classical sedatives, DSIP does not produce acute behavioural sedation, motor coordination loss, or impaired alertness. Instead it modulates sleep architecture toward a higher proportion of slow-wave sleep when the subject does sleep, without increasing total sleep time in non-sleep-deprived subjects. This distinct profile is one of the reasons DSIP has remained a compound rather than a clinical sedative. <\/p>\n<h3>Can DSIP and Epitalon be stacked in studies?<\/h3>\n<p>Yes. DSIP and Epitalon act on different timescales and biological compartments (acute EEG-level sleep architecture vs gene-expression-level circadian regulation), so co-administration is not pharmacologically redundant. Study protocols studying combined sleep-quality and circadian-rhythm endpoints frequently use both peptides. <\/p>\n<h3>Does DSIP cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation. Long-term human safety data is limited because the peptide has not undergone modern Western regulatory review. The small size and lack of identified primary receptor are consistent with the clean tolerability profile. <\/p>\n<h3>Quelle est la demi-vie du DSIP ?<\/h3>\n<p>In preclinical studies, DSIP has a plasma half-life of approximately 7\u201315 minutes following intravenous or subcutaneous administration. The short plasma half-life is offset by the peptide&#8217;s ability to cross the blood-brain barrier and produce effects on sleep architecture and gene expression that persist well beyond plasma clearance. <\/p>\n<h3>Pourquoi le DSIP a-t-il \u00e9t\u00e9 isol\u00e9 \u00e0 l'origine ?<\/h3>\n<p>Le DSIP a \u00e9t\u00e9 identifi\u00e9 en 1977 par Schoenenberger et Monnier \u00e0 l'Universit\u00e9 de B\u00e2le en dialysant le sang veineux c\u00e9r\u00e9bral de lapins pendant la stimulation \u00e9lectrique du thalamus intralaminaire \u2014 une r\u00e9gion du cerveau connue pour induire le sommeil \u00e0 ondes delta (ondes lentes). Ils ont concentr\u00e9 la fraction bioactive et caract\u00e9ris\u00e9 le peptide qui produisait l'effet le plus fort sur l'EEG du sommeil lorsqu'il \u00e9tait transf\u00e9r\u00e9 \u00e0 des animaux receveurs. Le peptide a \u00e9t\u00e9 nomm\u00e9 d'apr\u00e8s sa signature \u00e9lectroenc\u00e9phalographique dominante : une activit\u00e9 accrue des ondes delta pendant le sommeil. <\/p>\n<h3>How long does DSIP take to show effects in preclinical studies?<\/h3>\n<p>Les effets aigus sur l'architecture du sommeil et la proportion d'ondes delta dans l'EEG sont d\u00e9tectables d\u00e8s la premi\u00e8re session de sommeil suivant l'administration. Les effets sur l'axe HPA et la r\u00e9activit\u00e9 au stress s'accumulent sur 7 \u00e0 14 jours de dosage r\u00e9gulier. Les effets anti-sevrage dans les mod\u00e8les de sevrage aux opio\u00efdes et \u00e0 l'alcool sont g\u00e9n\u00e9ralement mesur\u00e9s sur des p\u00e9riodes de sevrage de 3 \u00e0 7 jours. <\/p>\n<h3>Puis-je commander du DSIP pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die le DSIP dans le monde entier depuis notre r\u00e9seau d'exp\u00e9dition d\u00e9di\u00e9 aux peptides. Les commandes de peptides uniquement sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition de peptides autonome. Toutes les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet et sont couvertes par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\">Politique de R\u00e9exp\u00e9ditions Garanties<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Sleep, Circadian, and CNS Studies<\/h2>\n<ul>\n<li><a href=\"\/fr\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 pineal-melatonin axis and circadian gene-expression studies<\/li>\n<li><a href=\"\/fr\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/fr\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Nootropique heptapeptidique d\u00e9velopp\u00e9 en Russie \u2014 modulation m\u00e9lanocortine et dopaminergique<\/li>\n<li><a href=\"\/fr\/oxytocin-acetate\/\"><strong>Ac\u00e9tate d'ocytocine<\/strong><\/a> \u2014 9-aa cyclic nonapeptide \u2014 social-bonding and affiliative behavioural support<\/li>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore sleep, circadian, and CNS peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Parcourez toute la <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\"><strong>catalogue de peptides<\/strong><\/a>, avec des compos\u00e9s apparent\u00e9s incluant <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> for circadian gene-expression studies, <a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a> for anxiolytic stress-axis studies, and <a href=\"https:\/\/medsbase.com\/fr\/oxytocin-acetate\/\">Ac\u00e9tate d'ocytocine<\/a> for social-bonding behavioural support.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Peptide inducteur de sommeil delta (d\u00e9couverte de 1977)<br \/>\n\u2705 Module l'architecture du sommeil \u00e0 ondes lentes<br \/>\n\u2705 HPA-axis stress reactivity<br \/>\n\u2705 Anti-sevrage et analg\u00e9sie non opio\u00efde<br \/>\n\u2705 Traverse la barri\u00e8re h\u00e9mato-enc\u00e9phalique<\/p>\n<p><strong>DSIP<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70946,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6275,5441],"class_list":["post-70711","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-dsip","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/70711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=70711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70946"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=70711"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=70711"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=70711"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=70711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}